Ligand Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.About LGND
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV.
LGND Key Statistics
Stock Snapshot
With a market cap of 3.74B, Ligand Pharmaceuticals(LGND) trades at $189.55. The stock has a price-to-earnings ratio of 91.24.
During the trading session on 2025-12-14, Ligand Pharmaceuticals(LGND) shares reached a daily high of $190.17 and a low of $181.78. At a current price of $189.55, the stock is +4.3% higher than the low and still -0.3% under the high.
Trading volume for Ligand Pharmaceuticals(LGND) stock has reached 273.85K, versus its average volume of 227.5K.
Over the past 52 weeks, Ligand Pharmaceuticals(LGND) stock has traded between a high of $212.49 and a low of $93.58.
Over the past 52 weeks, Ligand Pharmaceuticals(LGND) stock has traded between a high of $212.49 and a low of $93.58.
LGND News
In December 2025, Ligand Pharmaceuticals issued 2026 guidance calling for total revenue of US$245 million to US$285 million, including US$200 million to US$225...
Analyst Robert Wasserman from Benchmark Co. maintained a Buy rating on Ligand Pharma and keeping the price target at $220.00. TipRanks Cyber Monday Sale Claim 6...